Stern Colin D

Avg. Two Year Performance

No purchase track record
(32%) Avg. Sale Return
(15%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(4%)4%(6%)(24%)(32%)
Sale Success Rate1 of 43 of 42 of 41 of 42 of 4
Drugs » Biotechnology

EVP, General Counsel & Sec.:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--